The Harvard Drug Group LLC recalls
6 recalls filed under The Harvard Drug Group LLC. The most recent was published July 1, 2026.
-
Class II · 4 months ago
The Harvard Drug Group LLC Carton Label: Major, Methylergonovine Maleate Tablets recall: Subpotent Drug
Subpotent Drug
-
Class II · 6 months ago
The Harvard Drug Group LLC Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram recall: Failed Capsule Specifications: Out of specification results obtained during
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
-
Class II · 6 months ago
The Harvard Drug Group LLC Memantine Hydrochloride Extended-Release, Capsules recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 8 months ago
The Harvard Drug Group LLC Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets recall: Defective container; inadequately sealed blister packaging
Defective container; inadequately sealed blister packaging.
-
Class II · 12 months ago
The Harvard Drug Group LLC Gabapentin Capsules, USP, 100 mg, 100 Capsules recall: Failed Impurities/Degradation Specifications: an out of specification result
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
-
Class II · 12 months ago
The Harvard Drug Group LLC Gabapentin Capsules, USP, 100 mg, 10 Capsules recall: Failed Impurities/Degradation Specifications: an out of specification result
Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
About this page
The Harvard Drug Group LLC appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.